Search research articles
Contact Us
Filters
Showing results (171-180 of 201) with videos related to
Page
of 21
Sort By:
Plos One
|
July 2, 2025
VIVALDI-CT shaping care home COVID-19 testing policy: A pragmatic cluster randomised controlled trial of asymptomatic testing compared to standard care in care home staff
Oliver Stirrup, James Blackstone, Iona Cullen-Stephenson, et al.
BMC Public Health
|
April 18, 2015
Participatory women's groups and counselling through home visits to improve child growth in rural eastern India: protocol for a cluster randomised controlled trial
Nirmala Nair, Prasanta Tripathy, Harshpal S Sachdev, et al.
BMJ Open
|
February 10, 2022
Intimate physical contact between people from different households during the COVID-19 pandemic: a mixed-methods study from a large, quasi-representative survey (Natsal-COVID)
Pam Sonnenberg, Dee Menezes, Lily Freeman, et al.
The Journal of Infectious Diseases
|
June 27, 2025
Risk factors associated with TB infection among household contacts of microbiologically confirmed pulmonary TB patients in three high TB burden countries
Thobani Ntshiqa, Jeniffer Nagudi, Yohhei Hamada, et al.
Health and Social Care Delivery Research
|
February 16, 2026
Asymptomatic testing compared with standard care of the care home staff in shaping care home COVID-19 testing policy: the VIVALDI-CT pragmatic cluster RCT (VIVALDI-CT)
Natalie Adams, Oliver Stirrup, James Blackstone, et al.
Communications Biology
|
January 3, 2026
Endemic penetrance of SARS-CoV-2 has impacted marginally on immunity to spike protein of human coronaviruses
Tara Lancaster, Gokhan Tut, Panagiota Sylla, et al.
The Lancet. Healthy Longevity
|
August 25, 2021
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study
Gokhan Tut, Tara Lancaster, Maria Krutikov, et al.
Plos One
|
September 19, 2025
Evaluation of QIAreach QuantiFERON-TB lateral-flow nanoparticle fluorescence assay for TB infection diagnosis among TB household contacts in three high-burden settings
Thobani Ntshiqa, Akinlolu Fasanmi, Jeniffer Nagudi, et al.
BMJ (Clinical Research Ed.)
|
November 11, 2018
Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration
Karla Hemming, Monica Taljaard, Joanne E McKenzie, et al.
The Journal of Infectious Diseases
|
April 16, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI)
Oliver Stirrup, Maria Krutikov, Gokhan Tut, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 201) with videos related to
Sort By:
Page
of 21
Plos One
|
July 2, 2025
VIVALDI-CT shaping care home COVID-19 testing policy: A pragmatic cluster randomised controlled trial of asymptomatic testing compared to standard care in care home staff
Oliver Stirrup, James Blackstone, Iona Cullen-Stephenson, et al.
BMC Public Health
|
April 18, 2015
Participatory women's groups and counselling through home visits to improve child growth in rural eastern India: protocol for a cluster randomised controlled trial
Nirmala Nair, Prasanta Tripathy, Harshpal S Sachdev, et al.
BMJ Open
|
February 10, 2022
Intimate physical contact between people from different households during the COVID-19 pandemic: a mixed-methods study from a large, quasi-representative survey (Natsal-COVID)
Pam Sonnenberg, Dee Menezes, Lily Freeman, et al.
The Journal of Infectious Diseases
|
June 27, 2025
Risk factors associated with TB infection among household contacts of microbiologically confirmed pulmonary TB patients in three high TB burden countries
Thobani Ntshiqa, Jeniffer Nagudi, Yohhei Hamada, et al.
Health and Social Care Delivery Research
|
February 16, 2026
Asymptomatic testing compared with standard care of the care home staff in shaping care home COVID-19 testing policy: the VIVALDI-CT pragmatic cluster RCT (VIVALDI-CT)
Natalie Adams, Oliver Stirrup, James Blackstone, et al.
Communications Biology
|
January 3, 2026
Endemic penetrance of SARS-CoV-2 has impacted marginally on immunity to spike protein of human coronaviruses
Tara Lancaster, Gokhan Tut, Panagiota Sylla, et al.
The Lancet. Healthy Longevity
|
August 25, 2021
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study
Gokhan Tut, Tara Lancaster, Maria Krutikov, et al.
Plos One
|
September 19, 2025
Evaluation of QIAreach QuantiFERON-TB lateral-flow nanoparticle fluorescence assay for TB infection diagnosis among TB household contacts in three high-burden settings
Thobani Ntshiqa, Akinlolu Fasanmi, Jeniffer Nagudi, et al.
BMJ (Clinical Research Ed.)
|
November 11, 2018
Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration
Karla Hemming, Monica Taljaard, Joanne E McKenzie, et al.
The Journal of Infectious Diseases
|
April 16, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI)
Oliver Stirrup, Maria Krutikov, Gokhan Tut, et al.
Page
of 21